Prostacyclins
- 6 August 2013
- book chapter
- Published by Springer Nature
- Vol. 218, 177-198
Abstract
Prostacyclins have a favourable pharmacological profile for treatment of pulmonary hypertension as they possess vasodilative, antiproliferative, antiaggregatory, and anti-inflammatory properties that may compensate the main pathologic changes in the small pulmonary...Keywords
This publication has 89 references indexed in Scilit:
- Bloodstream Infections in Patients With Pulmonary Arterial Hypertension Treated With Intravenous Prostanoids: Insights From the REVEAL REGISTRY®Mayo Clinic Proceedings, 2012
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- Short- and Long-Term Effects of Inhaled Iloprost Therapy in Children With Pulmonary Arterial HypertensionJACC, 2008
- Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytesBritish Journal of Pharmacology, 2007
- Favorable Effects of Inhaled Treprostinil in Severe Pulmonary HypertensionJACC, 2006
- How should we treat portopulmonary hypertension?European Respiratory Journal, 2006
- Efficacy and Safety of Sildenafil Added to Treprostinil in Pulmonary HypertensionThe American Journal of Cardiology, 2005
- Induction of Hyaluronic Acid Synthase 2 (HAS2) in Human Vascular Smooth Muscle Cells by Vasodilatory ProstaglandinsCirculation Research, 2004
- Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.Circulation, 1982
- Prostaglandins, Platelets, And AtherosclerosiCritical Reviews in Biochemistry, 1980